Skip to main content

NorthCrest Asset Manangement, LLC

Position in ABBV — AbbVie Inc.

CIK 1893159 PLYMOUTH, MN

Position in ABBV

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$25,305,924
+$4,318,139 QoQ
Shares Held
100,564
+4.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#536
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 4% Shared 0% None 96%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$603,936
PutShares
2,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

NorthCrest Asset Manangement, LLC holds $171,430,810 across 12 Drug Manufacturers - General names. ABBV ranks #3 (14.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ABBV
AbbVie Inc.
This page
100,564 $25,305,924

All Filings in ABBV

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,305,924 100,564
2026-06-30 $603,936 2,400
2026-03-31 $20,987,785 96,500
2025-12-31 $30,649,877 134,141
2025-09-30 $30,977,041 133,787
2025-06-30 $24,625,091 132,664
2025-03-31 $27,754,066 132,465
2024-12-31 $23,390,473 131,629
2024-09-30 $25,880,741 131,055
2024-09-30 $4,820 2,500
2024-06-30 $22,113,730 128,928
2024-06-30 $8,747 51
2024-03-31 $22,807,478 125,247
2024-03-31 $224 800
2023-12-31 $1,520 800
2023-12-31 $19,427,504 125,363
2023-09-30 $18,860,561 126,530
2023-09-30 $11,210 2,500
2023-06-30 $7,480 800
2023-03-31 $1,675 2,500
2022-12-31 $14,873,937 92,036
2022-09-30 $12,818,397 95,510
2022-06-30 $14,518,342 94,792
2022-03-31 $15,304,642 94,409
2021-12-31 $12,444,072 91,906